According to Insmed's latest financial reports the company's current earnings are A$0.36 Billion. a decrease over its 2023 earnings that were of -A$1.1 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | -A$1.35 Billion | 23.71% |
2023 | -A$1.1 Billion | 45.77% |
2022 | -A$0.75 Billion | 15.83% |
2021 | -A$0.65 Billion | 50.19% |
2020 | -A$0.44 Billion | 16.4% |
2019 | -A$0.37 Billion | -23.9% |
2018 | -A$0.49 Billion | 59.35% |
2017 | -A$0.31 Billion | 8.52% |
2016 | -A$0.29 Billion | 47.25% |
2015 | -A$0.2 Billion | 34.53% |
2014 | -A$0.15 Billion | 58.83% |
2013 | -A$89.27 Million | 35.14% |
2012 | -A$66.06 Million | -31.92% |
2011 | -A$97.03 Million | 854.92% |
2010 | -A$10.17 Million | -105.22% |
2009 | A$0.19 B | -905.06% |
2008 | -A$24.17 Million | -27.31% |
2007 | -A$33.25 Million | -62.41% |
2006 | -A$88.44 Million | 98.19% |
2005 | -A$44.63 Million | 0.03% |
2004 | -A$44.61 Million | 159.07% |
2003 | -A$17.22 Million | -69.31% |
2002 | -A$56.1 Million | |
2000 | -A$50.59 Million |